RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis ; volume:17 ; number:1 ; day:15 ; month:3 ; year:2019 ; pages:1-9 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (15.3.2019), 1-9, 12.2019
- Urheber
-
Jhun, Jooyeon
Lee, Seung Hoon
Kim, Se-Young
Ryu, Jaeyoon
Kwon, Ji Ye
Na, Hyun Sik
Jung, KyoungAh
Moon, Su-Jin
Cho, Mi-La
Min, Jun-Ki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1809-3
- URN
-
urn:nbn:de:101:1-2019040719594513572510
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jhun, Jooyeon
- Lee, Seung Hoon
- Kim, Se-Young
- Ryu, Jaeyoon
- Kwon, Ji Ye
- Na, Hyun Sik
- Jung, KyoungAh
- Moon, Su-Jin
- Cho, Mi-La
- Min, Jun-Ki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2
MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice
R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
Metformin attenuates lung fibrosis development via NOX4 suppression
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
IL‐33 attenuates the development of experimental autoimmune uveitis
Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2
MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice
R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
Metformin attenuates lung fibrosis development via NOX4 suppression
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
IL‐33 attenuates the development of experimental autoimmune uveitis
Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
Sigma‐1 receptor attenuates osteoclastogenesis by promoting ER‐associated degradation of SERCA2
MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice
R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
Metformin attenuates lung fibrosis development via NOX4 suppression
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
IL‐33 attenuates the development of experimental autoimmune uveitis